Kostenis; Evi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kostenis; Evi.The latest application filed is for "gpr 17 agonists and screening assay".

Company Profile

0.14.23

Kostenis; Evi - Bonn DE
Kostenis; Evi - Hoersholm SE
Kostenis; Evi - Grebenau DE
Kostenis; Evi - Frankfurt am Main DE
Kostenis, Evi - Humlebaek DK
Kostenis, Evi - Frankfurt DE
Kostenis; Evi - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
GPR 17 agonists and screening assay Grant 8,623,593 - Kostenis , et al. January 7, 2	2014-01-07
Gpr 17 Agonists And Screening Assay App 20130338374 - Kostenis; Evi ; et al.	2013-12-19
GPR 17 Agonists and Screening Assay App 20130158093 - Kostenis; Evi ; et al.	2013-06-20
Methods of identifying modulators of GPR17 Grant 8,404,436 - Kostenis , et al. March 26, 2	2013-03-26
Methods Of Identifying Modulators Of Gpr17 App 20130059899 - Kostenis; Evi ; et al.	2013-03-07
Association Of Edg5 Polymorphism V286a With Type Ii Diabetes Mellitus And Venous Thrombosis/pulmonary Embolism And The Use Thereof App 20120208200 - KOZIAN; Detlef ; et al.	2012-08-16
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Grant 8,198,022 - Kozian , et al. June 12, 2	2012-06-12
CRTH2 receptor ligands for medicinal uses App 20110269763 - Ulven; Trond ; et al.	2011-11-03
CRTH2 receptor ligands for medicinal uses Grant 8,022,063 - Ulven , et al. September 20, 2	2011-09-20
Association Of Edg5 Polymorphism V286a With Type Ii Diabetes Mellitus And Venous Thrombosis/pulmonary Embolism And The Use Thereof App 20110104704 - Kozian; Detlef ; et al.	2011-05-05
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Grant 7,888,020 - Kozian , et al. February 15, 2	2011-02-15
Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1 Grant 7,794,927 - Kostenis , et al. September 14, 2	2010-09-14
CRTH2 Receptor Ligands For Therapeutic Use App 20090105218 - Ulven; Trond ; et al.	2009-04-23
CRTH2 Receptor Ligands For Medicinal Uses App 20090099189 - Ulven; Trond ; et al.	2009-04-16
Process for identifying modulators of G-protein-coupled receptors Grant 7,378,252 - Kostenis May 27, 2	2008-05-27
Substituted Thiazoleacetic Acid as Crth2 Ligands App 20080119456 - Ulven; Trond ; et al.	2008-05-22
Method for identifying compounds for treating aging processes in the coronary circulatory system Grant 7,348,155 - Kostenis , et al. March 25, 2	2008-03-25
Association Of Edg5 Polymorphism V286a With Type Ii Diabetes Mellitus And Venous Thrombosis/pulmonary Embolism And The Use Thereof App 20070298509 - KOZIAN; Detlef ; et al.	2007-12-27
Method for identifying agonists and antagonists of the GPR45-like/GPR63 receptor Grant 7,300,764 - Kostenis , et al. November 27, 2	2007-11-27
Method For Identifying Agonists Or Antagonists Of The G-protein Coupled Receptor Mas-like 1 App 20070259378 - Kostenis; Evi ; et al.	2007-11-08
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Grant 7,262,273 - Kozian , et al. August 28, 2	2007-08-28
Use of EDG2 receptor in an animal model of heart failure Grant 7,169,612 - Kostenis , et al. January 30, 2	2007-01-30
EDG8 receptor, its preparation and use Grant 7,141,383 - Kostenis , et al. November 28, 2	2006-11-28
Process for identifying modulators of G-protein-coupled receptors App 20050255531 - Kostenis, Evi	2005-11-17
Novel promiscuous G alpha protein mutants and their use App 20050042720 - Kostenis, Evi	2005-02-24
Use of EDG2 receptor in an animal model of heart failure App 20040132182 - Kostenis, Evi ; et al.	2004-07-08
Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 App 20040029180 - Kostenis, Evi ; et al.	2004-02-12
Process for identifying modulators of G-protein-coupled receptors App 20040002109 - Kostenis, Evi	2004-01-01
Method for identifying agonists and antagonists of the GPR45-like/GPR63 receptor App 20030235871 - Kostenis, Evi ; et al.	2003-12-25
Method for identifying compounds for treating aging processes in the coronary circulatory system App 20030100484 - Kostenis, Evi ; et al.	2003-05-29
Method for identifying ligands for G protein-coupled receptors App 20020182655 - Kostenis, Evi ; et al.	2002-12-05
Process for identifying modulators of G-protein-coupled receptors App 20020127601 - Kostenis, Evi	2002-09-12
EDG8 receptor, its preparation and use App 20020099191 - Kostenis, Evi ; et al.	2002-07-25
Methods and compositions for identifying modulators of G-protein-coupled receptors Grant 6,383,761 - Conklin , et al. May 7, 2	2002-05-07
Methods And Compositions For Identifying Modulators Of G-protein-coupled Receptors App 20010053532 - CONKLIN, BRUCE R. ; et al.	2001-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.